Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kymera Therapeutics (KYMR) Other Non-Current Assets: 2019-2025

Historic Other Non-Current Assets for Kymera Therapeutics (KYMR) over the last 6 years, with Sep 2025 value amounting to $6.8 million.

  • Kymera Therapeutics' Other Non-Current Assets rose 18.07% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year increase of 18.07%. This contributed to the annual value of $5.8 million for FY2024, which is 0.29% down from last year.
  • Latest data reveals that Kymera Therapeutics reported Other Non-Current Assets of $6.8 million as of Q3 2025, which was up 17.32% from $5.8 million recorded in Q2 2025.
  • Kymera Therapeutics' 5-year Other Non-Current Assets high stood at $6.8 million for Q3 2025, and its period low was $1.6 million during Q2 2021.
  • Its 3-year average for Other Non-Current Assets is $5.9 million, with a median of $5.8 million in 2023.
  • Over the last 5 years, Kymera Therapeutics' Other Non-Current Assets had its largest YoY gain of 698.99% in 2021, and its largest YoY loss of 11.18% in 2021.
  • Over the past 5 years, Kymera Therapeutics' Other Non-Current Assets (Quarterly) stood at $6.1 million in 2021, then increased by 0.23% to $6.1 million in 2022, then dropped by 5.20% to $5.8 million in 2023, then declined by 0.29% to $5.8 million in 2024, then climbed by 18.07% to $6.8 million in 2025.
  • Its Other Non-Current Assets stands at $6.8 million for Q3 2025, versus $5.8 million for Q2 2025 and $5.8 million for Q1 2025.